{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:46:33Z","timestamp":1791225993877,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-12-EMMA-0032-02"],"award-info":[{"award-number":["ANR-12-EMMA-0032-02"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.biomaterials.2015.01.056","type":"journal-article","created":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T21:30:21Z","timestamp":1424295021000},"page":"164-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"special_numbering":"C","title":["Porous nanoparticles as delivery system of complex antigens for an effective vaccine against acute and chronic Toxoplasma gondii infection"],"prefix":"10.1016","volume":"50","author":[{"given":"Isabelle","family":"Dimier-Poisson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolphe","family":"Carpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Thanh Loi","family":"N'Guyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Dahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Ducournau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Betbeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2015.01.056_bib1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1586\/erv.12.28","article-title":"Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis","volume":"11","author":"Pliaka","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib2","first-page":"10","article-title":"Recent progress in adjuvant discovery for peptide-based subunit vaccines","author":"Azmi","year":"2013","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2014.05.011","article-title":"Combatting infectious diseases; nanotechnology as a platform for rational vaccine design","volume":"74","author":"van Riet","year":"2014","journal-title":"Adv Drug Deliv Rev 74,"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nmat2960","article-title":"Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses","volume":"10","author":"Moon","year":"2011","journal-title":"Nat Mater"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib5","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1039\/B914943K","article-title":"Designing polymeric particles for antigen delivery","volume":"40","author":"De Koker","year":"2011","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib6","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/nbt1332","article-title":"Exploiting lymphatic transport and complement activation in nanoparticle vaccines","volume":"25","author":"Reddy","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib7","doi-asserted-by":"crossref","first-page":"18264","DOI":"10.1073\/pnas.0509541102","article-title":"In\u00a0vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles","volume":"102","author":"Kwon","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature09737","article-title":"Programming the magnitude and persistence of antibody responses with innate immunity","volume":"470","author":"Kasturi","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib9","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1469-0691.2002.00485.x","article-title":"Toxoplasma gondii: transmission, diagnosis and prevention","volume":"8","author":"Hill","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib10","series-title":"Toxoplasmosis: a comprehensive clinical guide","first-page":"74","year":"2001"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib11","first-page":"289","article-title":"Protozoan infections (Toxoplasma gondii, Neospora caninum and Sarcocystis spp.) in sheep and goats: recent advances","volume":"29","author":"Buxton","year":"1998","journal-title":"Veterinary Res"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0169-4758(88)90018-X","article-title":"Pathophysiology of toxoplasmosis","volume":"4","author":"Frenkel","year":"1988","journal-title":"Parasitol Today"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.11.4.569","article-title":"Regulation and function of T-cell mediated immunity during Toxoplasma gondii infection","volume":"11","author":"Denkers","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4049\/jimmunol.146.1.286","article-title":"Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine","volume":"146","author":"Gazzinelli","year":"1991","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4049\/jimmunol.149.1.175","article-title":"Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii","volume":"149","author":"Gazzinelli","year":"1992","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.3128869","article-title":"Interferon-\u03b3: the major mediator of resistance against Toxoplasma gondii","volume":"240","author":"Suzuki","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib17","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.4049\/jimmunol.140.11.3943","article-title":"Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice","volume":"140","author":"Suzuki","year":"1988","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1348-0421.1994.tb01858.x","article-title":"CD8(+) T lymphocytes are the major cell population involved in the early gamma interferon response and resistance to acute primary Toxoplasma gondii infection in mice","volume":"38","author":"Shirahata","year":"1994","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib19","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.4049\/jimmunol.152.4.1856","article-title":"Antigen-specific CD8(+) T cell clone protects against acute Toxoplasma gondii infection in mice","volume":"152","author":"Khan","year":"1994","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1128\/IAI.70.2.434-443.2002","article-title":"CD8+-T-cell immunity against Toxoplasma gondii can be induced but not maintained in mice lacking conventional CD4+ T cells","volume":"70","author":"Casciotti","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib21","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib23","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.4049\/jimmunol.147.10.3496","article-title":"Protection of mice from fatal Toxoplasma gondii infection by immunization with p30 antigen in liposomes","volume":"147","author":"Bulow","year":"1991","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib24","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.vaccine.2009.01.100","article-title":"Protective immunity against Toxoplasma challenge in mice by coadministration of T.\u00a0gondii antigens and Eimeria profilin-like protein as an adjuvant","volume":"27","author":"Hedhli","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib25","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1128\/IAI.00425-12","article-title":"The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can control parasite burden","volume":"80","author":"Grover","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/intimm\/dxu063","article-title":"Challenges in mucosal vaccines for the control of infectious diseases","volume":"26","author":"Azegami","year":"2014","journal-title":"Int Immunol"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib27","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1128\/iai.64.6.2158-2166.1996","article-title":"Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection","volume":"64","author":"Debard","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib28","first-page":"301","article-title":"Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens","volume":"59","author":"Lycke","year":"1986","journal-title":"Immunology"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib29","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.4049\/jimmunol.132.6.2736","article-title":"Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin","volume":"132","author":"Elson","year":"1984","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.nano.2010.01.001","article-title":"Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies","volume":"6","author":"Klippstein","year":"2010","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib31","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1016\/j.vaccine.2009.07.037","article-title":"Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice","volume":"27","author":"Okamoto","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib32","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1016\/j.vaccine.2009.03.047","article-title":"Induction of humoral and enhanced cellular immune responses by novel core-shell nanosphere- and microsphere-based vaccine formulations following systemic and mucosal administration","volume":"27","author":"Caputo","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib33","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1016\/S0264-410X(02)00191-3","article-title":"Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses","volume":"20","author":"Debin","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib34","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biomaterials.2012.08.070","article-title":"Airway delivery of peptides and proteins using nanoparticles","volume":"34","author":"Dombu","year":"2013","journal-title":"Biomaterials"},{"issue":"35","key":"10.1016\/j.biomaterials.2015.01.056_bib35","doi-asserted-by":"crossref","first-page":"9117","DOI":"10.1016\/j.biomaterials.2012.08.064","article-title":"Influence of surface charge and inner composition of nanoparticles on intracellular delivery of proteins in airway epithelial cells","volume":"33","author":"Dombu","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib36","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.1128\/IAI.71.11.6222-6228.2003","article-title":"The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis","volume":"71","author":"Ismael","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib37","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11095-009-9986-z","article-title":"Positively-charged, porous, polysaccharide nanoparticles loaded with anionic molecules behave as 'stealth' cationic nanocarriers","volume":"27","author":"Paillard","year":"2010","journal-title":"Pharm Res"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib38","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.1039\/C4NR01202J","article-title":"In\u00a0vivo delivery of bovine viral diahorrea virus, E2 protein using hollow mesoporous silica nanoparticles","volume":"6","author":"Mahony","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib39","first-page":"2045","article-title":"Cellular entry of nanoparticles via serum sensitive clathrin-mediated endocytosis, and plasma membrane permeabilization","volume":"7","author":"Smith","year":"2012","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2011.07.014","article-title":"Study of serum interaction with a cationic nanoparticle: Implications for in\u00a0vitro endocytosis, cytotoxicity and genotoxicity","volume":"423","author":"Merhi","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib41","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib42","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.4049\/jimmunol.179.2.1129","article-title":"Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii","volume":"179","author":"Debierre-Grockiego","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biomaterials.2015.01.056_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1379\/CSC-138R.1","article-title":"Toxoplasma gondii-derived heat shock protein 70 stimulates maturation of murine bone marrow-derived dendritic cells via Toll-like receptor 4","volume":"11","author":"Aosai","year":"2006","journal-title":"Cell Stress Chaperones"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961215000733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961215000733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:06:51Z","timestamp":1758902811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961215000733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":43,"alternative-id":["S0142961215000733"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2015.01.056","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Porous nanoparticles as delivery system of complex antigens for an effective vaccine against acute and chronic Toxoplasma gondii infection","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2015.01.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}